TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 1 | -2 | 5 | -7 | -3 | -4 | -2 |
| P | %wins | 33 | 33 | 67 | 33 | 67 | 67 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/26/23 16:05 | 12/21/23 | CYCC | Cyclacel Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McBarron Paul | NJ | DO | See Rema | P.d | 6 | 3.32 | 0 | 2 | 6 | 33 | D | ||||||||||||||
5/22/13 17:30 | 5/21/13 | CYCC | Cyclacel Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McBarron Paul | NJ | DO | EVP,Fina | P | 39 | 3.03 | 0 | 13 | 23 | 70 | D | -72 | -9 | -34 | -47 | -40 | -31 | -23 | 2 | 6 | 12 | 2 | -4 | 45 | 2 |
9/26/11 20:45 | 9/23/11 | CYCC | Cyclacel Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McBarron Paul | NJ | DO | EVP,Fina | P | 6 | 0.5000 | 0 | 12 | 7 | 188 | D | -48 | -71 | -62 | -62 | -37 | -35 | -30 | -30 | -2 | -10 | 16 | 0 | 32 | 45 |
5/23/08 14:19 | 5/22/08 | CYCC | Cyclacel Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McBarron Paul | NJ | DO | E.VP,Fin | P | 4 | 2.25 | 0 | 2 | 3 | 76 | D | -69 | -72 | -57 | -44 | -23 | -22 | -7 | -6 | -2 | -7 | -4 | -18 | -86 | -58 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |